American Biogenetic Sciences, Inc. - Statements of Cash Flows (USD $)	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Net loss	$ (35,560)	$ (43,456)
Expenses paid by issuance of common stock	0	0
Fair value of services provided by related parties	28,000	33,000
Increase (decrease) in accounts payable and accrued expenses	7,560	10,456
Cash flows used by operating activities	0	0
Cash used in investing activities	0	0
Procceds from related party borrowings	0	0
Cash generated by financing activities	0	0
Change in cash	0	0
Cash - beginning of period	0	0
Cash - end of period	$ 0	$ 0